Previous 10 | Next 10 |
Aurora Cannabis (NYSE: ACB) is one of the most popular marijuana stocks on the market today, but not everyone is a fan. Stifel analyst W. Andrew Carter recently lowered his rating on Aurora Cannabis' stock to "sell" from "hold." He also reduced his target price to CA$5 ($3.77) from CA$7 ($5...
You could easily come up with a relatively long list of reasons not to buy Aurora Cannabis (NYSE: ACB) . It remains unprofitable. The dilution of its shares has reached epic proportions. The company couldn't even meet revenue guidance that it provided less than a month before its quarterly ...
Canopy Growth ( CGC ) was one of our long-time favorites in the cannabis sector. However, after a series of mishaps, we downgraded the stock in August to Neutral. The stock was up >80% at one point in 2019 before the slump began in recent months. Despite no immediate risk of collapse, we ar...
Aurora Cannabis Announces Date of Annual General Meeting Canada NewsWire EDMONTON, Sept. 20, 2019 TSX: ACB | NYSE: ACB EDMONTON , Sept. 20, 2019 /CNW/ - Aurora Cannabis Inc. (the " Company " or " Aurora ") (NYSE | TSX: ACB), the Canadian company defining the future...
MKM partners initiates coverage on seven pot stocks: Curaleaf Holdings ( OTCPK:CURLF ): Sell, Aurora Cannabis (NYSE: ACB ): Sell ( -1% ), Canopy Growth (NYSE: CGC ): Neutral (up a fraction), Tilray (NASDAQ: TLRY ): Neutral (up a fraction), Cronos Group (NASDAQ: CRON ): Neutral ( +1% ), ...
"Nobody loves you when you're down and out." Aurora Cannabis (NYSE: ACB) is finding out just how true the line from the old blues song is. The stock sank last week after it whiffed on fourth-quarter revenue guidance that it had provided less than a month earlier. Now the big Canadian ca...
September 19, 2019 Palm Beach, FL –September 19, 2019 – Consumer demand is a powerful force. It can make or break a product or even an industry… but the increasing consumer appetite for Cannabis – CBD infused products are showing that it can even stabil...
Aurora Cannabis (NYSE: ACB) released its quarterly results last week, which failed to impress investors as the stock has fallen since then. Although the company showed significant sales growth from the previous year, there were still some areas of concern that should have investors thin...
Cannabis has become the hottest investment story of the year with no shortage of bullish analysts. For example, according to the Marijuana Business Factbook, the industry could be worth $77 billion by 2022. Analysts at Arcview Market Research and BDS Analytics see worldwide sales of $55 billi...
Investing in cannabis stocks can be a daunting business, particularly if you’re not familiar with the industry. There can be a whole host of terms and phrases that can be difficult to get your head around, and even with the ones that are relatively self-explanatory, it can be just ...
News, Short Squeeze, Breakout and More Instantly...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injecte...
Cannabis stocks Canopy Growth Corporation (NASDAQ:CGC), Aurora Cannabis, Inc. (NASDAQ:ACB) and Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $12.22 on volume of 208,602,591 shares CytomX Therapeutics Inc. (CTMX) rose 214.7% to $5.13 on volume of 203,288,355 shares Akanda Corp. (AKAN) rose 25.4% to $0.1166 on volume of 179,349,234 shares ...